Dr. Eduardo Vilar-Sanchez
Claim this profileM D Anderson Cancer Center
Studies Colorectal Cancer
Studies Lynch Syndrome
5 reported clinical trials
8 drugs studied
Area of expertise
1Colorectal Cancer
MLH1 positive
MSH6 positive
PMS2 positive
2Lynch Syndrome
MLH1 positive
MSH6 positive
PMS2 positive
Affiliated Hospitals
Clinical Trials Eduardo Vilar-Sanchez is currently running
Naproxen + Aspirin
for Lynch Syndrome
To learn about the effects of naproxen and aspirin on the normal colon in people with Lynch Syndrome.
Recruiting3 awards Phase 215 criteria
Obeticholic Acid
for Familial Adenomatous Polyposis
This phase IIa trial investigates if giving obeticholic acid (OCA) is safe and has a beneficial effect on the number of polyps in the small bowel and colon in patients with familial adenomatous polyposis (FAP). FAP is a rare gene defect that increases the risk of developing cancer of the intestines and colon. OCA is a drug similar to a bile acid the body makes. It is fluid made and released by the liver. OCA binds to a receptor in the intestine that is believed to have a positive effect on preventing cancer development. OCA has been effective in treating primary biliary cholangitis (PBC), a liver disease, and is approved by the Food and Drug Administration (FDA) for use at a lower dose (10 mg). There have been studies showing that OCA decreases inflammation and fibrosis. However, it is not yet known whether OCA works on reducing the number of polyps in patients with FAP.
Recruiting0 awards Phase 2
More about Eduardo Vilar-Sanchez
Clinical Trial Related1 year of experience running clinical trials · Led 5 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Eduardo Vilar-Sanchez has experience with
- Nous-209
- Aspirin
- Naproxen
- Obeticholic Acid
- Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5
- Nogapendekin Alfa
Breakdown of trials Eduardo Vilar-Sanchez has run
Colorectal Cancer
Lynch Syndrome
Syndrome
Adenomatous Polyposis
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eduardo Vilar-Sanchez specialize in?
Eduardo Vilar-Sanchez focuses on Colorectal Cancer and Lynch Syndrome. In particular, much of their work with Colorectal Cancer has involved MLH1 positive patients, or patients who are MSH6 positive.
Is Eduardo Vilar-Sanchez currently recruiting for clinical trials?
Yes, Eduardo Vilar-Sanchez is currently recruiting for 4 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Eduardo Vilar-Sanchez has studied deeply?
Yes, Eduardo Vilar-Sanchez has studied treatments such as Nous-209, Aspirin, Naproxen.
What is the best way to schedule an appointment with Eduardo Vilar-Sanchez?
Apply for one of the trials that Eduardo Vilar-Sanchez is conducting.
What is the office address of Eduardo Vilar-Sanchez?
The office of Eduardo Vilar-Sanchez is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.